BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34099314)

  • 1. Prospective analysis of circulating metabolites and endometrial cancer risk.
    Dossus L; Kouloura E; Biessy C; Viallon V; Siskos AP; Dimou N; Rinaldi S; Merritt MA; Allen N; Fortner R; Kaaks R; Weiderpass E; Gram IT; Rothwell JA; Lécuyer L; Severi G; Schulze MB; Nøst TH; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Gurrea AB; Schmidt JA; Palli D; Agnoli C; Tumino R; Sacerdote C; Mattiello A; Vermeulen R; Heath AK; Christakoudi S; Tsilidis KK; Travis RC; Gunter MJ; Keun HC
    Gynecol Oncol; 2021 Aug; 162(2):475-481. PubMed ID: 34099314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC.
    Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Sieri S; Tumino R; Bueno-de-Mesquita B; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Perez-Cornago A; Assi N; Riboli E; Tsilidis KK; Key TJ; Travis RC
    Int J Cancer; 2020 Feb; 146(3):720-730. PubMed ID: 30951192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.
    Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Floegel A; Boeing H; Trichopoulou A; Lagiou P; Anifantis E; Agnoli C; Palli D; Trevisan M; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Redondo-Sánchez D; Barricarte A; Huerta JM; Quirós JR; Wareham N; Khaw KT; Perez-Cornago A; Johansson M; Cross AJ; Tsilidis KK; Riboli E; Key TJ; Travis RC
    BMC Med; 2017 Jul; 15(1):122. PubMed ID: 28676103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition.
    Kliemann N; Viallon V; Murphy N; Beeken RJ; Rothwell JA; Rinaldi S; Assi N; van Roekel EH; Schmidt JA; Borch KB; Agnoli C; Rosendahl AH; Sartor H; Huerta JM; Tjønneland A; Halkjær J; Bueno-de-Mesquita B; Gicquiau A; Achaintre D; Aleksandrova K; Schulze MB; Heath AK; Tsilidis KK; Masala G; Panico S; Kaaks R; Fortner RT; Van Guelpen B; Dossus L; Scalbert A; Keun HC; Travis RC; Jenab M; Johansson M; Ferrari P; Gunter MJ
    BMC Med; 2021 Apr; 19(1):101. PubMed ID: 33926456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort.
    Carayol M; Leitzmann MF; Ferrari P; Zamora-Ros R; Achaintre D; Stepien M; Schmidt JA; Travis RC; Overvad K; Tjønneland A; Hansen L; Kaaks R; Kühn T; Boeing H; Bachlechner U; Trichopoulou A; Bamia C; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Quirós JR; Sánchez-Cantalejo E; Huerta JM; Ardanaz E; Arriola L; Agudo A; Nilsson J; Melander O; Bueno-de-Mesquita B; Peeters PH; Wareham N; Khaw KT; Jenab M; Key TJ; Scalbert A; Rinaldi S
    J Proteome Res; 2017 Sep; 16(9):3137-3146. PubMed ID: 28758405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults.
    Bagheri M; Djazayery A; Farzadfar F; Qi L; Yekaninejad MS; Aslibekyan S; Chamari M; Hassani H; Koletzko B; Uhl O
    Lipids Health Dis; 2019 Apr; 18(1):94. PubMed ID: 30967146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer.
    Knific T; Vouk K; Smrkolj Š; Prehn C; Adamski J; Rižner TL
    J Steroid Biochem Mol Biol; 2018 Apr; 178():312-321. PubMed ID: 29360580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients.
    Vouk K; Ribič-Pucelj M; Adamski J; Rižner TL
    J Steroid Biochem Mol Biol; 2016 May; 159():60-9. PubMed ID: 26921767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
    Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition.
    Breeur M; Ferrari P; Dossus L; Jenab M; Johansson M; Rinaldi S; Travis RC; His M; Key TJ; Schmidt JA; Overvad K; Tjønneland A; Kyrø C; Rothwell JA; Laouali N; Severi G; Kaaks R; Katzke V; Schulze MB; Eichelmann F; Palli D; Grioni S; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Olsen KS; Sandanger TM; Nøst TH; Quirós JR; Bonet C; Barranco MR; Chirlaque MD; Ardanaz E; Sandsveden M; Manjer J; Vidman L; Rentoft M; Muller D; Tsilidis K; Heath AK; Keun H; Adamski J; Keski-Rahkonen P; Scalbert A; Gunter MJ; Viallon V
    BMC Med; 2022 Oct; 20(1):351. PubMed ID: 36258205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach.
    Floegel A; Stefan N; Yu Z; Mühlenbruch K; Drogan D; Joost HG; Fritsche A; Häring HU; Hrabě de Angelis M; Peters A; Roden M; Prehn C; Wang-Sattler R; Illig T; Schulze MB; Adamski J; Boeing H; Pischon T
    Diabetes; 2013 Feb; 62(2):639-48. PubMed ID: 23043162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study.
    Gaudet MM; Falk RT; Stevens RD; Gunter MJ; Bain JR; Pfeiffer RM; Potischman N; Lissowska J; Peplonska B; Brinton LA; Garcia-Closas M; Newgard CB; Sherman ME
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3216-23. PubMed ID: 22730518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Harewood R; Rothwell JA; Bešević J; Viallon V; Achaintre D; Gicquiau A; Rinaldi S; Wedekind R; Prehn C; Adamski J; Schmidt JA; Jacobs I; Tjønneland A; Olsen A; Severi G; Kaaks R; Katzke V; Schulze MB; Prada M; Masala G; Agnoli C; Panico S; Sacerdote C; Jakszyn PG; Sánchez MJ; Castilla J; Chirlaque MD; Atxega AA; van Guelpen B; Heath AK; Papier K; Tong TYN; Summers SA; Playdon M; Cross AJ; Keski-Rahkonen P; Chajès V; Murphy N; Gunter MJ
    EBioMedicine; 2024 Mar; 101():105024. PubMed ID: 38412638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of mammographic density in premenopausal women.
    His M; Lajous M; Gómez-Flores-Ramos L; Monge A; Dossus L; Viallon V; Gicquiau A; Biessy C; Gunter MJ; Rinaldi S
    Breast Cancer Res; 2021 Jul; 23(1):75. PubMed ID: 34301304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective analysis of circulating metabolites and breast cancer in EPIC.
    His M; Viallon V; Dossus L; Gicquiau A; Achaintre D; Scalbert A; Ferrari P; Romieu I; Onland-Moret NC; Weiderpass E; Dahm CC; Overvad K; Olsen A; Tjønneland A; Fournier A; Rothwell JA; Severi G; Kühn T; Fortner RT; Boeing H; Trichopoulou A; Karakatsani A; Martimianaki G; Masala G; Sieri S; Tumino R; Vineis P; Panico S; van Gils CH; Nøst TH; Sandanger TM; Skeie G; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Schmidt JA; Travis RC; Riboli E; Tsilidis KK; Christakoudi S; Gunter MJ; Rinaldi S
    BMC Med; 2019 Sep; 17(1):178. PubMed ID: 31547832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Cust AE; Kaaks R; Friedenreich C; Bonnet F; Laville M; Tjønneland A; Olsen A; Overvad K; Jakobsen MU; Chajès V; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Lukanova A; Boeing H; Pischon T; Trichopoulou A; Christina B; Trichopoulos D; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Gram IT; Lund E; Quirós JR; Travier N; Martínez-García C; Larrañaga N; Chirlaque MD; Ardanaz E; Berglund G; Lundin E; Bueno-de-Mesquita HB; van Duijnhoven FJ; Peeters PH; Bingham S; Khaw KT; Allen N; Key T; Ferrari P; Rinaldi S; Slimani N; Riboli E
    Endocr Relat Cancer; 2007 Sep; 14(3):755-67. PubMed ID: 17914105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.
    Zeleznik OA; Clish CB; Kraft P; Avila-Pacheco J; Eliassen AH; Tworoger SS
    J Natl Cancer Inst; 2020 Jun; 112(6):628-636. PubMed ID: 31593240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling.
    Kozar N; Kruusmaa K; Dovnik A; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Takač I; Arko D
    Adv Med Sci; 2021 Mar; 66(1):46-51. PubMed ID: 33360772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.
    Cust AE; Allen NE; Rinaldi S; Dossus L; Friedenreich C; Olsen A; Tjønneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Chang-Claude J; Boeing H; Schulz M; Benetou V; Trichopoulou A; Trichopoulos D; Palli D; Berrino F; Tumino R; Mattiello A; Vineis P; Quirós JR; Agudo A; Sánchez MJ; Larrañaga N; Navarro C; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Bingham S; Khaw KT; Key T; Slimani N; Riboli E; Kaaks R
    Int J Cancer; 2007 Jun; 120(12):2656-64. PubMed ID: 17285578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
    Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
    Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.